Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Crossref DOI link: https://doi.org/10.1007/s13555-018-0247-0
Published Online: 2018-06-18
Published Print: 2018-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Skov, Torsten http://orcid.org/0000-0002-1918-3340
Stockfleth, Eggert
Szeimies, Rolf-Markus
Berman, Brian
Funding for this research was provided by:
LEO Pharma A/S
Article History
Received: 5 April 2018
First Online: 18 June 2018